Aldesleukin Active Not Recruiting Phase N/A Trials for Metastatic Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01005745Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
NCT01701674Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts